16. Brady M, Oza A, Cunney R, Burns K. Attributable mortality of hospital‐acquired bloodstream infections in Ireland. J Hosp Infect. 2017;96(1):35‐41 https://doi.org/10.1016/j.jhin.2017.02.006. 17. Burke JPY, T.W. Nosocomial urinary tract infections. In: Mayhall CG, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams and Wilkins; 2004. 18. Khanafer N, Barbut F, Eckert C, Perraud M, Demont C, Luxemburger C, et al. Factors predictive of severe Clostridium difficile infection depend on the definition used. Anaerobe. 2016;37:43‐8 https://doi.org/10.1016/j.anaerobe.2015.08.002. 19. Johnson SG, D.N.;. Clostridium difficile. In: Mayhall CG, editor. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams and Wilkins; 2004. 20. Ressler A, Wang J, Rao K. Defining the black box: a narrative review of factors associated with adverse outcomes from severe Clostridioides difficile infection. Therap Adv Gastroenterol. 2021;14:17562848211048127 https://doi.org/10.1177/17562848211048127. 21. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128‐40 https://doi.org/10.1016/0196‐ 6553(88)90053‐3. 22. Gastmeier P. European perspective on surveillance. J Hosp Infect. 2007;65 Suppl 2:159‐64 https://doi.org/10.1016/S0195‐6701(07)60036‐X. 23. Schröder C, Schwab F, Behnke M, Breier AC, Maechler F, Piening B, et al. Epidemiology of healthcare associated infections in Germany: Nearly 20 years of surveillance. Int J Med Microbiol. 2015;305(7):799‐806 https://doi.org/10.1016/j.ijmm.2015.08.034. 24. Geubbels EL, Nagelkerke NJ, Mintjes‐De Groot AJ, Vandenbroucke‐Grauls CM, Grobbee DE, De Boer AS. Reduced risk of surgical site infections through surveillance in a network. Int J Qual Health Care. 2006;18(2):127‐33 https://doi.org/10.1093/intqhc/mzi103. 25. Badia‐Cebada L, Penafiel J, Saliba P, Andres M, Camara J, Domenech D, et al. Trends in the epidemiology of catheter‐related bloodstream infections; towards a paradigm shift, Spain, 2007 to 2019. Euro Surveill. 2022;27(19) https://doi.org/10.2807/1560‐ 7917.ES.2022.27.19.2100610. 26. Centers for Disease Control and Prevention (CDC). Bloodstream Infection Event (Central Line‐Associated Bloodstream Infection and Non‐central Line Associated Bloodstream Infection) Atlanta, USA: Centers for Disease Control and Prevention; 2023 [Available from: https://www.cdc.gov/nhsn/psc/bsi/. 27. Gross PA. Dramatic improvements in healthcare quality: you can do it too. In: Mayhall CG, editor. Hospital Epidemiology and Infection Prevention: Lippincott Williams & Wilkins; 2004. 28. Berenholtz SM, Pronovost PJ, Lipsett PA, Hobson D, Earsing K, Farley JE, et al. Eliminating catheter‐related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32(10):2014‐20 https://doi.org/10.1097/01.ccm.0000142399.70913.2f. 29. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter‐related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725‐32 https://doi.org/10.1056/NEJMoa061115. 30. Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD. The 100,000 lives campaign: setting a goal and a deadline for improving health care quality. JAMA. 2006;295(3):324‐7 https://doi.org/10.1001/jama.295.3.324. 31. Ista E, van der Hoven B, Kornelisse RF, van der Starre C, Vos MC, Boersma E, et al. Effectiveness of insertion and maintenance bundles to prevent central‐line‐associated 16 Chapter 1
RkJQdWJsaXNoZXIy MTk4NDMw